
Industry Partnerships & Commercialization
The Industry Partnerships and Commercialization (IP&C) Office at The Hospital for Sick Children (SickKids) champions the identification, development, and commercialization of cutting-edge health innovations from SickKids researchers, partnering with industry and investors to translate these innovations into impactful healthcare services and products worldwide.
Transforming SickKids Innovation into Global Health Impact
At IP&C, our team comprises individuals with deep scientific expertise and extensive experience in patenting, licensing, commercial transactions, and startup ventures.
We go beyond traditional tech transfer roles by assisting SickKids Innovators in de-risking their discoveries, maximizing their value, and aligning with investor interests.
Discover how we connect ideas, industry, and investors to create efficient pathways for commercializing research and technology developed at SickKids by watching our video!
Latest News
Innovation Showcase returns to highlight SickKids technologies and innovators Summary: Annual commercialization event offers attendees access to emerging therapeutic and diagnostic SickKids technologies with high potential [...]
Whole-genome detection and interpretation of repeat expansions in autism and related disorders Ryan Yuen, PhD Scientist | Genetics & Genome Biology Technology 1-Pager Lab Website [...]
Machine learning-driven NGS-based diagnostic tests to optimize clinical response in oncology Adam Shlien, PhD Associate Director | Translation Genetics Department of Paediatric Laboratory Medicine Uri Tabori, [...]
MATCH: Machine learning algorithms for toxicity and cardiac health Jason Maynes, PhD/MD Senior Scientist | Molecular Medicine Technology 1-Pager Lab Website [...]